ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DCGO vs MRK // FREE CASH FLOW YIELD

DocGo Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: DCGO 0 — MRK 9
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCGO VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DCGO MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 74.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 20.70% -55.70 MRK /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — 3.42% — TIE /fcf-yield <GO>
Operating Margin -55.30% 34.30% -89.60 MRK /operating-margins <GO>
Net Profit Margin -60.00% 28.10% -88.10 MRK /net-margins <GO>
Revenue Growth (YoY) -47.70% 1.30% -49.00 MRK /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 5.19 -4.99 MRK /balance-sheet <GO>
Piotroski F-Score Quality 5/9 7/9 -2.00 MRK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.1 51.7 -12.60 MRK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $27.0M $361.02B -$360.99B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DCGO REV MRK REV DCGO GROSS % MRK GROSS % DCGO FCF MRK FCF
FY 2025 $322.2M $65.01B — 74.8% $29.9M $12.36B
FY 2024 $616.6M $64.17B — 76.3% $66.5M $18.10B
FY 2023 $624.3M $60.12B — — -$64.5M $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCGO // BETA —
MRK // BETA 0.92